Benzofuran‐isatin conjugates as potent VEGFR‐2 and cancer cell growth inhibitors
Author:
- 13 November 2019
- journal article
- research article
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 57 (1) , 510-516
Abstract
A series of benzofuran‐isatin conjugates 6a‐l and 7a,b tethered by various alkyl linkers were synthesized and evaluated for their VEGFR‐2 inhibitory activity and in vitro activity against a panel of cancer cell lines. Seven of them were comparable with or better than Sunitinib against all tested cancer cells, demonstrating benzofuran‐isatin conjugates were potential anticancer candidates. The mechanism study revealed that VEGFR‐2 was at least one of the targets for this kind of conjugates. The structure‐activity relationship demonstrated that the carbon spacer between benzofuran and isatin moieties, substituents on the C‐2 position of benzofuran moiety, and substituents on C‐3 as well as C‐5 position of isatin motif influenced the anticancer activity significantly, and the enriched structure‐activity relationship may provide an insight for rational design of more effective conjugates.Keywords
This publication has 11 references indexed in Scilit:
- Benzofuran-isatin hybrids tethered via different length alkyl linkers and their in vitro anti-mycobacterial activitiesBioorganic & Medicinal Chemistry, 2019
- Benzofuran–isatin Hybrids: Design, Synthesis, and In Vitro Anti‐cancer ActivitiesJournal of Heterocyclic Chemistry, 2019
- Benzofuran-isatin-imine hybrids tethered via different length alkyl linkers: Design, synthesis and in vitro evaluation of anti-tubercular and anti-bacterial activities as well as cytotoxicityEuropean Journal of Medicinal Chemistry, 2019
- Quinolone hybrids and their anti-cancer activities: An overviewEuropean Journal of Medicinal Chemistry, 2019
- Benzofuran-isatin-hydroxylimine/thiosemicarbazide hybrids: Design, synthesis and in vitro anti-mycobacterial activity evaluationChinese Chemical Letters, 2019
- Fluoroquinolone-isatin hybrids and their biological activitiesEuropean Journal of Medicinal Chemistry, 2019
- Design, synthesis and anti-mycobacterial activity evaluation of benzofuran-isatin hybridsEuropean Journal of Medicinal Chemistry, 2018
- Isatin derivatives with activity against apoptosis-resistant cancer cellsBioorganic & Medicinal Chemistry Letters, 2016
- Bioactive Benzofuran derivatives: A reviewEuropean Journal of Medicinal Chemistry, 2015
- Biological and medicinal significance of benzofuranEuropean Journal of Medicinal Chemistry, 2015